Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
Tito R MendozaLoretta A WilliamsKaren N KeatingJonathan SiegelCem ElbiAnna K NowakRaffit HassanBrian CuffelCharles S CleelandPublished in: Journal of patient-reported outcomes (2019)
Symptoms specific to a particular cancer, treatment method, or treatment site can be added to the core MDASI to create a tailored, "fit for purpose" instrument. We found the MDASI-MPM to be a valid, reliable, and responsive (sensitive) instrument for assessing the severity of symptoms of patients with MPM and their interference in patients' daily functioning.